p38-MAPK inhibitor RWJ-67657, Purity ≥98%

Cat. No.: X23-10-ZQ889

p38-MAPK inhibitor RWJ-67657, Purity ≥98%

Synonym: RWJ-67657; 215303-72-3; RWJ 67657; 4-(4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)but-3-yn-1-ol; 4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol; p38-MAPK inhibitor

  • CAS Number: 215303-72-3
  • Compound CID: 3008319
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
RWJ-67657 targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates.
Molecular Weight
425.49736
Molecular Formula
C27H24FN3O
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
RWJ-67657 can be used to analyze the effects of p38 MAP kinase inhibition in inflammation and cancer therapy.
Storage
Store at -20ºC.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0